Main Conference & Exhibition: Sept 19-21, 2023 | Workshops: Sept 18
Boston Convention and Exhibition CenterBoston, MAKey Sessions
Sanchayita Ghose, PhD
Keynote Address - Evolving Trends and Challenges in Development of Downstream Processes with Increasing Complexity of Biologics Portfolio
Bristol-Myers Squibb Company
Joseph Pekny
KEYNOTE: A Step-by-Step Guide for Achieving Data-Driven Smart Manufacturing and High Impact Manufacturing Social Media
Purdue University
keyboard_arrow_right
Search & Filter keyboard_arrow_right
keyboard_arrow_left Hide
Main Conference - Day 1 - EST/EDT (Eastern Daylight, GMT-4)
keyboard_arrow_leftSearch & Filter
search
Streams
Main Conference - Day 1 - EST/EDT (Eastern Daylight, GMT-4)
search
Streams
7:00am - 7:55am
Breakfast and Registration
Showing 8 of 8 Streams
Cell Culture & Upstream Processing - Room 210C
Recovery & Purification - Room 210B
Manufacturing Strategy & Bioprocessing 4.0 - Room 210A
Analytical & Quality - Room 209
Well Characterized Biologics & Biological Assays - Room 208
Cell Therapy Manufacturing - Room 206AB
Gene Edited Ex Vivo Manufacturing - Room 205C
In Vivo Gene Therapy Manufacturing - Room 205AB
7:55am - 8:00am
Chairperson’s Opening Remarks
- Charles Sardonini, PhD - Consultant to the Biotechnology Industry, Sardonini Consulting, LLC
8:00am - 8:30am
Using Modeling Approaches to Improve Efficiency in Upstream Process Development
- Zhuangrong Huang - Senior Scientist, Global Product Development and Supply, Bristol-Myers Squibb
8:30am - 9:00am
Digital Twin Modeling of a Small-Scale Model and Technology Transfer for Mammalian Cell Culture
- Woo Ahn, PhD - Principal Scientist, Upstream, MSAT, Sanofi
9:00am - 9:30am
Reactor Scale-Up by Advanced First-Principle Simulations
- Christian Witz - CEO, SimVantage
9:30am - 10:00am
In-line monitoring of bioprocess parameters for the 21st century
- Christopher Brown, PhD - Chief Technology Officer, 908 Devices
7:55am - 8:00am
Chairperson’s Opening Remarks
- Stefano Menegatti - Associate Professor, North Carolina State University
8:00am - 8:30am
Keynote Address - Evolving Trends and Challenges in Development of Downstream Processes with Increasing Complexity of Biologics Portfolio
- Sanchayita Ghose, PhD - Executive Director, Head of Global Downstream/Pilot Plant/External Manufacturing & DVN BD Site Head, Bristol-Myers Squibb Company
8:30am - 9:00am
Development and Scale-up of Robust Antibody Drug Conjugate Processes
- Laurie Mlinar - Principal Research Scientist, Process Engineering, AbbVie
9:00am - 9:30am
Vegan Cheese – Essential ingredients to set up a scalable and economic manufacturing process
- Christoph Herwig - Founder Lisalis GmbH, former Professor for Bioprocess Engineering, Körber Pharma Austria
9:30am - 10:00am
Designing Purification Strategies for Bispecific Antibodies Based on Molecule Design
- Josefin Bolik - Global Product Manager – Antibody Platforms, Cytiva
7:55am - 8:00am
Chairperson’s Opening Remarks
- Mark Duerkop - Chief Executive Officer, Novasign
8:00am - 8:30am
PAT Monitoring and Control Road Map
- Jessica Philpott - Manager Process Sciences, Regeneron
8:30am - 9:00am
Taking a holistic approach to develop a robust bioprocess that is fast to clinic and easy to scale up for non-MAB biologics
- Mark Yang, PhD - VP of CMC, Palleon Pharmaceuticals
9:00am - 9:30am
Single Use Assembly Defects and Investigation - Experience From A New Single Use Clinical Biologics Manufacturing Facility
- Roshan Shrestha - Single Use Expert (CSC) and DS Tech Team Lead (Global), Genentech
9:30am - 10:00am
Navigating the Digital Transformation for Biopharmaceutical Process Development: Harnessing the Power of Microbial Systems and Innovative Technologies
- Cécile Brocard - Director Downstream Development, Biopharma Process Science, Boehringer Ingelheim RCV GmbH & Co KG
7:55am - 8:00am
Chairperson’s Opening Remarks
- Da Ren - Founder and CEO, BioTherapeutics Solutions
8:00am - 8:30am
KEYNOTE ADDRESS – Specifying Spokes – Fit for Purpose Specifications
- Jeffrey Baker - Senior Fellow, NIIMBL; Strategic Advisor, CBI-MIT
8:30am - 9:00am
KEYNOTE ADDRESS – Emergence of Documentary Standards and Reference Materials for Biological Products
- Nadine Ritter, Ph.D. - President and Analytical Advisor, Global Biotech Experts, LLC
9:00am - 9:30am
KEYNOTE ADDRESS - Total Analytical Control Strategy for Base Editing Gene Therapy
- Johnson Varghese - Head of Analytical Research & Development, Beam Therapeutics
9:30am - 10:00am
Online Amino Acid Analysis for Spend Media Control - Long-time Reaction Control Using the Agilent InfinityLab Online LC Solution
- Lorena Lopez - LC Applications Scientist, Agilent
7:55am - 8:00am
Chairperson’s Opening Remarks
- Da Ren - Founder and CEO, BioTherapeutics Solutions
8:00am - 8:30am
KEYNOTE ADDRESS – Specifying Spokes – Fit for Purpose Specifications
- Jeffrey Baker - Senior Fellow, NIIMBL; Strategic Advisor, CBI-MIT
8:30am - 9:00am
KEYNOTE ADDRESS – Emergence of Documentary Standards and Reference Materials for Biological Products
- Nadine Ritter, Ph.D. - President and Analytical Advisor, Global Biotech Experts, LLC
9:00am - 9:30am
KEYNOTE ADDRESS - Total Analytical Control Strategy for Base Editing Gene Therapy
- Johnson Varghese - Head of Analytical Research & Development, Beam Therapeutics
9:30am - 10:00am
Advanced Orthogonal Methods to Fully Characterize Process HCPs
- Eric Bishop - Vice President of Research & Development, Cygnus Technologies
7:55am - 10:00am
CGT Opening Plenary Session in In Vivo Gene Therapy Room 205AB
7:55am - 10:00am
CGT Opening Plenary Session in In Vivo Gene Therapy Room 205AB
7:55am - 8:00am
Chairperson’s Opening Remarks
- Morten Sogaard - President and Division Head, Gene Therapy Research and Technical Operations, Astellas Gene Therapies
8:00am - 8:40am
Keynote: State of the Industry and Future Perspectives for Cell and Gene Therapies
- Tim Hunt - CEO, Alliance for Regenerative Medicine
8:40am - 9:20am
Keynote: Partnering to Enable Industrialization of Allogeneic Cell Therapy
- Thomas Bieringer - SVP, Global Head of AMES, Bayer
- Aaron Dulgar-Tulloch - CTO, Genomic Medicine, Cytiva
9:20am - 9:40am
Keynote: A Robust Scalable Suspension Process for AAV Manufacturing
- Samir Acharya - Associate Director of Process Development, Andelyn Biosciences
9:40am - 10:00am
Keynote: Genomic Medicine Keeps Innovating. Manufacturing Should Too.
- Clive Glover, PhD - Business Leader, Viral Vectors, Cytiva
10:00am - 10:10am
Transition to Breakfast Presentations
Showing 5 of 5 Streams
Sponsored Breakfast Presentation 1
Sponsored Breakfast Presentation 2
Sponsored Breakfast Presentation 3
Sponsored Breakfast Presentation 4
Sponsored Breakfast Presentation 5
10:10am - 10:40am
Vector Purification Strategies for Gene Therapy
- William H. Rushton, MS - Chromatography Support Scientist, Bio-Rad
- Sushmita Koley, PhD - Senior Scientist, R&D Applications, Bio-Rad Laboratories
10:10am - 10:40am
Improved Cell Productivities for Fed-batch and Perfusion Processes with BalanCD CHO Media Platform
- Luis Rodriguez PhD - Bioproduction R&D Manager, Fujifilm Irvine
10:10am - 10:40am
The Evolution of Manufacturing Process: From mAb to Viral Vectors for Gene Therapy
- Rachel Legmann - Sr. Director of Technology, Gene Therapy, Repligen
10:10am - 10:40am
Out-of-the-Box Implementation of Optical Monitoring of Critical Process Parameters
- Nick Randall - Bioprocessing Product Manager, 908 Devices
10:10am - 10:40am
FUNDALOOP: Single-use and Multi-cycle Filters for Process Intensification
- Chloe Jerrold-Jones - Technical Sales Specialist - Single-Use Systems, DrM inc
10:40am - 10:55am
Networking Break
Showing 8 of 8 Streams
Cell Culture & Upstream Processing - Room 210C
Recovery & Purification - Room 210B
Manufacturing Strategy & Bioprocessing 4.0 - Room 210A
Analytical & Quality - Room 209
Well Characterized Biologics & Biological Assays - Room 208
Cell Therapy Manufacturing - Room 206AB
Gene Edited Ex Vivo Manufacturing - Room 205C
In Vivo Gene Therapy Manufacturing - Room 205AB
11:00am - 11:30am
KEYNOTE: Innovation to Advance a Multi‐modality Portfolio: Transition from a 20+ Year Legacy System to an Optimized End‐to‐end CHO Expression Platform
- Natalia Gomez - Director Process Development, Cell Line Development, Drug Substance Technologies, Amgen
11:30am - 12:00pm
Biocapacitance-Based Bioreactor Modeling, Simulation, and Control
- Sarwat Khattak - Head Of Cell Culture Development, Biogen
- Sarah Fadda - Practice Director for Upstream Bioprocessing, Siemens
12:00pm - 12:30pm
Case study: Increasing Upstream Process Production in a Tight Timeline
- Chao Ma - Principal Scientist, Upstream Process Development, Bioprocess Research & Development, Pfizer
11:00am - 11:30am
How to Guide for Multi-Specifics Purification: Identify Manufacturability Issues Early and Leverage the mAb Platform
- Yekaterina Lin, PhD - Senior Scientist II, Abbvie
11:30am - 12:00pm
Leveraging Risk-based Approach, Process Knowledge and Selecting Appropriate Strategies to Design Process Relevant Impurity Clearance Challenge Studies
- Raj Vijay - Principal Scientist, Alkermes
12:00pm - 12:30pm
Using Gaussian Process Regression to Enable Holistic Modeling and Robustness Analysis of Process Impurity Clearance in Biopharm Downstream Process
- Chris Gerberich - Principal Investigator, GSK
11:00am - 11:30am
Quality Assurance in a Virtual Environment
- Dawn Speidel - Director of Global Quality Assurance, Latham Bio
11:30am - 12:00pm
Scale-up of Biologics Produced through Microbial Fermentation
- Jack Greene - Chief Technical Officer, JucaBio
12:00pm - 12:30pm
KEYNOTE: A Step-by-Step Guide for Achieving Data-Driven Smart Manufacturing and High Impact Manufacturing Social Media
- Joseph Pekny - Professor, Chemical Engineering, Purdue University
- Jonathan Forstrom - Director, Manufacturing Science and Technology, Sanofi
11:00am - 11:30am
Integration of PAT and HTPD for streamlining high concentration UF/DF process development to enable subcutaneous product administration
- Jessica Hung - Principal Scientist, Bristol Myers Squibb
11:30am - 12:00pm
Recent progress towards real time LC‐ automated analysis and assessment of system suitability
- Nicole Ferreira - Associate Principal Scientist, Chemistry, Merck
- Jan Verelst - Global Business Development Manager SIPAT, Siemens
12:00pm - 12:30pm
Mass Spectrometry Enables More Definitive Process & Product Development Towards Well-Characterized Biotherapeutics: A Personal Account
- Jason Rouse, Ph.D. - Senior Director, Pfizer, Inc.
10:55am - 11:00am
Chairperson's Opening Remarks
- Sethu Alexander - Associate Director, Analytical Development-VRA, Takeda Pharmaceuticals
11:00am - 11:30am
Characterizing Color by online cIEF/MS and Peptide Mapping as a Result of Process Intensification of Biotherapeutics
- Kristen Nields - Senior Scientist, Janssen Biotech
11:30am - 12:00pm
Discovery of Oxidation Induced Crosslinks in a Recombinant Monoclonal Antibody
- Yi Yang, Ph.D. - Senior Scientist, Protein Chemistry Group, Genentech Inc
12:00pm - 12:30pm
Mass Spectrometry Enables More Definitive Process & Product Development Towards Well-Characterized Biotherapeutics: A Personal Account
- Jason Rouse, Ph.D. - Senior Director, Pfizer, Inc.
10:55am - 11:00am
Chairperson's Opening Remarks
- Lara Lonescu Silverman, PhD - Principal Consultant, LIS BioConsulting
11:00am - 11:30am
Keynote: Manufacturing Strategies for Cell Therapy Commercialization
- Robert Zamboldi - Site Head, US Cell & Gene Therapy, Morris Plains NJ, Novartis
11:30am - 12:00pm
Creating a completely closed process solution from multi-vendor off-the-shelf process tools resulting in a low investment semi-automated workflow to compete with “all in one” cell processing systems for human MSC expansion, harvest, and final fill
- Kyle Harvey, PharmD, PhD - Research Scientist, MED Institute Inc.
12:00pm - 12:30pm
Accelerating CAR-T Cell Manufacturing with a Next-Day Process and Automation
- Xavier de Mollerat du Jeu - Senior Director, Research and Development, Thermo Fisher Scientific, USA
10:55am - 11:00am
Chairperson's Opening Remarks
- Francesca Vitelli, PhD - VP Cell Therapy and Viral Vector PD and MSAT, Intellia Therapeutics, Inc
11:00am - 11:30am
Process Development for Autologous Gene-Edited Stem Cell Therapies
- Corrina Lucini - Scientist, Beam Therapeutics
11:30am - 12:00pm
Best Practices for Successful Tech Transfers
- Pia Mountford - Head of External Manufacturing, Cell and Genetic Therapies, Vertex Pharmaceuticals
10:55am - 11:00am
Chairperson's Opening Remarks
- Shashi Murthy, PhD - Co-Founder & CTO, Nanite
11:00am - 11:30am
Keynote: Scale Up and Commercial Manufacturing Strategies for Gene Therapy Products
- Craig Malzahn - Senior Vice President, Technical Operations, REGENXBIO Inc.
11:30am - 12:00pm
Keynote – Addressing the Challenges of Transferring and Manufacturing Gene Therapies Externally and At-Scale
- Ryan Bartock - VP & Head of Engineering, Technical & Digital, Spark Therapeutics
12:00pm - 12:30pm
How Novel Tools Can Accelerate AAV Development Timelines?
- Yatindra Tirunagari - Business Development Technical Specialist, Rentschler Biopharma
12:30pm - 12:45pm
Transition to Lunch Presentations
Showing 9 of 9 Streams
Sponsored Lunch Presentation 1
Sponsored Lunch Presentation 2
Sponsored Lunch Presentation 3
Sponsored Lunch Presentation 4
Sponsored Lunch Presentation 5
Sponsored Lunch Presentation 6
Sponsored Lunch Presentation 7
Sponsored Lunch Presentation 8
Sponsored Lunch Presentation 9
12:45pm - 1:30pm
Next top model: in silico design, scalability, and optimization of a bioreactor platform
- Neil Ross - Senior Global Product Marketing Manager, Cytiva
- Andreas Castan, PhD - Strategic Technologies Leader, Cytvia
- Kenneth Clapp - Sr. Bioreactor Technology, Applications and Integration Leader, Cytiva
12:45pm - 1:30pm
PUREcoli: A microbe reimagined for therapeutic protein expression
- Erik Nordwald - Associate Director, Process Technology and Innovation, KBI Biopharma
12:45pm - 1:30pm
Introducing KascadeTM– a Column-Free and Single-Use platform for High Recovery and High Efficiency Capture of AAVs and Other Biologics using Continuous Countercurrent Tangential Chromatography (CCTC)
- Oleg Shinkazh - CTO, Chromatan Corporation
12:45pm - 1:30pm
Panel Discussion: Process Intensification of Downstream Manufacturing: Defining Current Challenges and Exploring Future Perspectives
- James Sulzberger - Chromatography Consumables Product Specialist, Sartorius Stedim Biotech
- Keith Gillette - Product Specialist, Sartorius
- Kevin Brower - Global Head, Purification Development, Sanofi
- Thomas Erdenberger - Director, Manufacturing Services and Engineering, Resilience
- Cristina Peixoto - Head of Bioproduction Unit, iBET
12:45pm - 1:30pm
Developing Clone Agnostic Raman Feeding Strategies At A CDMO
- Thaddaeus Webster - R&D Supervisor, Lonza Biologics
- Bethany Silva - Industry Manager - Life Sciences, Endress+Hauser
12:45pm - 1:30pm
Straight Forward AAV Manufacturing Process Scale Up from Bench-Scale to 1000L
- Hanna Lesch - Chief Technology Officer, Exothera
- Daniel Koback - Bioprocess Applications Specialist, Polyplus
12:45pm - 1:30pm
Maximizing Protein Expression Efficiency through the S-CHOice® CLD Platform
- Janet Lee - Director of Cell Line Development, Samsung Biologics
12:45pm - 1:30pm
Viral Vector Manufacturing: How to Work with Technology and Service Providers to Overcome Challenges
- Sybil Danby - Global Commercial Leader, Viral Vectors, Cytiva
- Paul Herzich - Chief Technology Officer, Solid Biosiences, USA
- Susan D'Costa. PhD - Chief Technology Officer and Head of the AAV Business Unit, Genezen, USA
- Dan Leblanc - Chief Technology Officer, Ensoma
- Francesca Vitelli, PhD - VP Cell Therapy and Viral Vector PD and MSAT, Intellia Therapeutics, Inc
12:45pm - 1:30pm
Overcoming Cell and Gene Therapy Manufacturing Roadblocks: How Strategic Partnerships Enable Robust Early-Stage Clinical Manufacturing
- Sarah Li, Ph.D - Associate Director of Technical Support of Process Development and MSAT, GenScript Probio
- Huiyi Zhu - Associate Director of Technical Support, GenScript Probio
- Carmine Carpenito - PhD - Senior Director, Cell Therapy Laboratories, Comprehensive Cell Solutions
1:30pm - 1:55pm
Networking Break
Showing 8 of 8 Streams
Cell Culture & Upstream Processing - Room 210C
Recovery & Purification - Room 210B
Manufacturing Strategy & Bioprocessing 4.0 - Room 210A
Analytical & Quality - Room 209
Well Characterized Biologics & Biological Assays - Room 208
Cell Therapy Manufacturing - Room 206AB
Gene Edited Ex Vivo Manufacturing - Room 205C
In Vivo Gene Therapy Manufacturing - Room 205AB
1:55pm - 2:00pm
Chairperson’s Opening Remarks
- Muhammad "Arshad" Chaudhry - Principal Engineer, Alkermes
2:00pm - 2:30pm
Process development, optimization & modelling of a CHO fed-batch process to produce SARS-CoV-2 spike protein
- Juan Reyes Davila - PhD candidate, Polytechnique Montreal
2:30pm - 3:00pm
SEA’ING THE SEA PROCESS: IMPROVING PROCESS TO PRODUCT UNDERSTANDING FOR TUNING AFUCOSYLATION
- Shanta Boddapati - Senior Scientist, Bioprocess Development, Seagen
3:00pm - 3:30pm
Automated miniaturized assays to accelerate cell line development workflows
- Aurora Fabry-Wood PhD - Product Manager, PhenomeX
1:55pm - 2:00pm
Chairperson’s Opening Remarks
- Leslie Wolfe, PhD - Vice President, Process Development, KBI Biopharma
2:00pm - 2:30pm
Novel approaches and a holistic control strategy for host-cell protein clearance and control during biomanufacturing
- Divya Chandra - Scientist, Merck
2:30pm - 3:00pm
Multi-Product Resin Re-Use during Clinical cGMP Manufacturing
- Denise Tanis - Senior Engineer II, Alexion AstraZeneca Rare Disease
3:00pm - 3:30pm
Addressing viral clearance challenges through use of a novel biodegradable detergent
- Pranav Vengsarkar - Manager, Process Development, Avantor
1:55pm - 2:00pm
Chairperson’s Opening Remarks
- Dawn Speidel - Director of Global Quality Assurance, Latham Bio
2:00pm - 2:30pm
Developing a sustainability roadmap for the biopharmaceutical industry
- Yeshwanth Narendar - Head of R&D and Innovation, Saint-Gobain Life Sciences
2:30pm - 3:00pm
Better, leaner and faster Biosimilar development and manufacturing
- Andrew Falconbridge - Head of Pilot, Innovation and Excellence, Alvotech
3:00pm - 3:30pm
Advanced Semiconductor-Based Analytical Technologies for Better, Faster and more Integrated PAT
- Olivier Henry - Program Director, Life Science Technology, IMEC, Belgium
1:55pm - 2:00pm
Chairperson’s Opening Remarks
- Da Ren - Founder and CEO, BioTherapeutics Solutions
2:00pm - 2:30pm
Opportunity and Challenges in Implementing PAT Tools as Rapid Analytics during Process Development of Biologics
- Dhanuka Wasalathanthri, PhD - Senior Principal Scientist, Bristol Myers Squibb
2:30pm - 3:00pm
PAT Strategy for In-Line Protein Concentration Monitoring During UFDF
- Lunedt Gonzalez-Pepe - Scientist I, Alexion Pharmaceuticals, AstraZeneca Rare Disease Unit
3:00pm - 3:30pm
Real time end-to-end monitoring of analytical method performance from development labs to QC
- Neeraj Agrawal - Director, Amgen
1:55pm - 2:00pm
Chairperson’s Opening Remarks
- Sethu Alexander - Associate Director, Analytical Development-VRA, Takeda Pharmaceuticals
2:00pm - 2:30pm
Accelerating Method Preparation to Speed Up Development Timelines
- Aaron Morgan - Director of QC Analytical, Wheeler Bio
2:30pm - 3:00pm
Structure Function Relationship Evaluation of Biosimilar Candidate: Case Study of Sialic Acid Challenge
- Xiaoxiao Liu - Process Development Scientist, Amgen
3:00pm - 3:30pm
Reducing Risk in the Biomanufacturing cold chain: The Durable Primary Packaging Solution
- Joe Cintavey - Product Manager, Gore & Associates
1:55pm - 2:00pm
Chairperson’s Opening Remarks
- Lara Lonescu Silverman, PhD - Principal Consultant, LIS BioConsulting
2:00pm - 3:00pm
Panel Discussion: Cell and Gene Therapy CDMO Selection and External Manufacturing Best Practices
- Amish Patel - SVP Technical Operations, Calidi Biotherapeutics
- Joseph Graskemper - Founder & Principal, Pathways Pharma Consulting, LLC
- Brian Greven - Sr. Director of Operations, Matica Biotechnology Inc.
- Catherine Tomaro-Duchesneau, PhD - Senior Director of Manufacturing Science & Technology, RoslinCT
- Venkata Indurthi, PhD - Chief Scientific Officer, Aldevron
3:00pm - 3:30pm
Leveraging the TESSATM Technology for Versatile AAV Manufacturing
- Seiga Ohmine - Head of Global Technical Sales, Wuxi Advanced Therapies
1:55pm - 2:00pm
Chairperson’s Opening Remarks
- Francesca Vitelli, PhD - VP Cell Therapy and Viral Vector PD and MSAT, Intellia Therapeutics, Inc
2:00pm - 2:30pm
Development and Commercialization of Gamma-Delta T Cell Therapies
- Kate Rochlin - Chief Operating Officer, IN8bio, USA
2:30pm - 3:00pm
Tiered-Characterization and Release-Testing of Gene-Edited iPSCs for Use as Starting Materials for Early-Phase Cell Therapy Manufacturing
- Leanne Jamieson - Manager of Quality Control, Notch Therapeutics Inc.
3:00pm - 3:30pm
Improving the Purification of Viral Vectors for Gene Therapy Using a Novel Cell Lysis Solution
- Courtney O'dell, MS - Senior Scientist, Avantor
1:55pm - 2:00pm
Chairperson’s Opening Remarks
- Shashi Murthy, PhD - Co-Founder & CTO, Nanite
2:00pm - 2:30pm
The Only Constant is Change: Demonstrating Control and Comparability in Gene Therapy Products
- Sarah Thomas - Senior Vice President, Quality, REGENXBIO Inc.
2:30pm - 3:00pm
Build it Right: A Quality Perspective on the Design and Build of a Viral Vector CDMO Manufacturing Facility
- Chris Berger - Executive Director, Quality, Viral Vector, Avid Bioservices
3:00pm - 3:15pm
AAV Production with All-In-One Stable ELEVECTATM Producer Cell Lines – High Vector Quality at Large Scale
- Vanessa Kress, PhD - Business Development Manager, CEVEC – now part of Cytiva
Showing 2 of 2 Streams
Break and Exhibition Hall Opening
BWB Main Stage
3:30pm - 4:30pm
Afternoon Break and Grand Opening of the Exhibit Hall
4:20pm - 4:25pm
Welcome from Informa Connect
4:25pm - 4:30pm
Chairpersons Opening Remarks
- Anne Montgomery - Editor in Chief, BioProcess International Magazine, Informa
Showing 1 of 1 Streams
BWB Main Stage
4:30pm - 5:30pm
Leading with Passion and Compassion
Every successful leader must know what they are fighting for—and to know that whatever “it” is that you’re fighting for, it’s bigger than you and bigger than all of us. John F. Crowley believes leading with passion and compassion is exactly what the biotech industry needs today. John will share his entrepreneurial journey that led him to success at multiple biotech companies, how the rare disease community, including two of his children who have Pompe disease, are the reason he continues to fight and actionable tips for leaders shaping the future of biotech
- John Crowley - Executive Chairman, Amicus Therapeutics
Showing 2 of 2 Streams
Break
Power Hour Exhibit Tour
5:30pm - 7:00pm
Cocktail Reception in Exhibit & Poster Hall & Product Launch Power Hour
5:40pm - 6:50pm
POWER HOUR EXHIBIT TOUR
Visit five key exhibitors on this tour who will present a demo or other brief introduction to their products or service:
- Asahi Kasei Bioprocess
- Another Inline Buffer Formulation Innovation from Asahi Kasei Bioprocess: Stop by Booth 627 to see the newest addition to our MOTIV family of inline buffer formulations systems – built to produce complex buffers on-demand effectively and efficiently in a safety-forward, simple design. Our own Nainesh Shah, Senior Project Engineer, will provide an in-depth presentation of our latest automated system and answer any questions you may have.
- Parker Hannifin
- Looking for Single Use Technologies? Explore Parker's Turnkey Solutions: Meet us in Booth 1144 to get details on our portfolio of Automated Bioprocessing Systems and Single Use Assemblies, Containers, and Tubing products designed to streamline your manufacturing demands.
- Avantor
- Viral inactivation solution/Quattro mixer in action: Viral inactivation - Addressing viral clearance challenges through use of a novel biodegradable detergent
- OmniBRx Biotechnologies
- “Would you like to know more about the world's first closed-loop, integrated & and automated, Vial-to Harvest production platform for vaccine and viral vector manufacturing? Stop by our booth#1321 at BPI, where you can witness the world of “Limitless bioprocessing”.
Get the Latest Event Updates
Sign up to get the latest event updates and information.
Filter
Streams